An in vitro study demonstrated that the PDE5 inhibition by sildenafil increases the intracellular levels of cGMP which, in turn, potentiates the mitogen-activated protein kinase (MAPK)-dependent melanoma cell growth [45] and increases the risk of tumorigenic effect [46]. This evidence concerns the gene PDE5A and melanoma.